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ABSTRACT: Silk-based matrix was produced for delivery of a
model anticancer drug, methotrexate (MTX). The calculation
of net charge of silk ﬁbroin and MTX was performed to better
understand the electrostatic interactions during matrix
formation upon casting. Silk ﬁbroin ﬁlms were cast at pH
7.2 and pH 3.5. Protein kinase A was used to prepare
phosphorylated silk ﬁbroin. The phosphorylation content of
matrix was controlled by mixing at speciﬁc ratios the
phosphorylated and unphosphorylated solutions. In vitro
release proﬁling data suggest that the observed interactions
are mainly structural and not electrostatical. The release of MTX is facilitated by use of proteolytic enzymes and higher pHs. The
elevated β-sheet content and crystallinity of the acidiﬁed-cast ﬁbroin solution seem not to favor drug retention. All the acquired
data underline the prevalence of structural interactions over electrostatical interactions between methotrexate and silk ﬁbroin.
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1. INTRODUCTION
In the past decades considerable attention has been drawn
toward the production of biocompatible and bioinspired
materials based on silk ﬁbroins.1 Silk possesses remarkable
properties such as high mechanical strength, low degradability,
and immunogenicity.1 Silk is a material of choice for many
applications, because it is easily isolated from source cocoons
and can be processed to obtain a variety of morphologically
diﬀerent devices.2 Examples include silk-based materials for
tissue regeneration,3 drug delivery systems,4 and modulation of
host immune responses5 among others.
As a tool of material engineering, phosphorylation remains
largely unexplored. Yet, in nature, phosphorylation plays a
fundamental role in protein stabilization and allosteric control.6
Thus, phosphorylation can be used as a tool to develop new
materials. In a previous work,7 modulation of hydrophobicity
and crystalline content of silk ﬁbroin based materials was done
through in vitro phosphorylation of regenerated silk using the
protein kinase A (PKA). It is known that, under physiological
conditions, the phospho-Ser residues of a protein bear a double
negative charge8 which considerably inﬂuences their micro-
environment.9 A correlation between phospho-Ser amount and
the physicochemical properties of the produced ﬁlms was
observed, due to increased negative charge and loosened
structure of phosphorylated chains.
Methotrexate (MTX) is a known folate antagonist, applied in
chemotherapy for a broad range of human malignancies (those
overexpressing folate receptors on their surfaces10). MTX
usage, however, may be restricted due to undesired side eﬀects,
like the toxicity to hematopoietic and gastrointestinal tissues11
and nephrotoxicity.12 Eventually, cancer cells may acquire
resistance to MTX by diﬀerent mechanisms, mostly by a
defective transport of the drug,13 thus compromising its
therapeutic eﬀect.
Hence, the emerged idea of controlled release of antitumor
agents poses attraction as it allows for a more uniform and
prolonged level of a circulating drug, accordingly lessening the
negative side eﬀects. The eﬃciency of MTX and similar
compounds that require prolonged administration of the drug
for eﬃcient cancer treatment is increased. Various strategies of
MTX-containing formulations for medical research are
currently being attempted. Among several, the injectable,
thermosensitive polymeric hydrogels for intra-articular deliv-
ery;14 combined magnetite−chitosan microspheres;15 and
gelatin-based16 and chitosan-based17 nanoparticles have been
prepared. Other carrier systems of MTX delivery are known: a
nanostructured lipid carrier18 and a sophisticated dextran−
peptide−MTX autocleaved conjugate construct.19 In this
context, materials for controlled delivery and/or release of
MTX, based on silk ﬁbroin, are described by solely one report
of silk-albumin nanoparticles20 and two patents21,22 dealing
with the same formulation type.
In this work we studied the eﬀect of phosphorylation and the
casting conditions on a solid matrix for the delivery of MTX.
Casting was done at pH 3.5 and pH 7.2 when both MTX and
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phosphorylated ﬁbroin have similar charges. Initially, theoretical
net charge of silk as a function of phosphorylation level and the
pH of resulting solution was estimated. For MTX the charge
was also estimated throughout the range of discrete pH values.
Later, by combining dynamic light scattering (DLS)23 and
electrophoretic mobility measurements,24 the empirical net
charges of both compounds were determined. Diﬀerential
scanning calorimetry (DSC) and release proﬁling of MTX from
the polymeric matrixes of silk ﬁbroin were performed to
elucidate the nature of interactions between both molecules. A
hypothesis of prolonged release of MTX from ﬁlms of diﬀerent
hydrophobicity and varying incubation buﬀer conditions was
empirically examined. A trial was made to ﬁnd, in terms of pH,
a favorable condition for polymer−drug interactions (whether
structural or electrostatic, or both) to be used in solution-cast
ﬁbroin ﬁlm production.
2. MATERIALS AND METHODS
2.1. Materials. Silk cocoons from Bombyx mori were
supplied from ‘‘Sezione Specializzata per la Bachicoltura’’
(Padova, Italy). Kinase-GLO luminescent kinase assay kit
(Cat. No. V6712) and CellTiter 96 Aqueous One Solution
were obtained from Promega Corporation, USA. Tissue culture
test microplates were from TPP Techno Plastic Products AG,
Switzerland, and Whatman grade 2 ﬁlter paper (Cat. No. 1002-
070) was from Whatman, USA.
2.2. Preparation of Silk Fibroin Solution. Sericin content
was removed from the silk as described elsewhere.25 Fibroin
solution of ﬁnal 2 wt % was prepared. The concentration of silk
ﬁbroin was assessed via the dry weight method on Whatman
paper, in triplicate.
2.3. Preparation of Phospho-Silk Fibroin Films and
MTX Loading. Dialyzed raw silk ﬁbroin solution was
phosphorylated using protein kinase A (EC 2.7.1.37) as
reported.7 The phospho-silk solution (of pH ≈7.25) was then
divided and the pH of one part adjusted to ≈3.5 using a 50%
aqueous HCl. Consequently, kinase reaction buﬀer was added
to the unreacted, raw ﬁbroin solution, and the mixture pH was
adjusted to ≈3.5 value, or left untreated. Finally, the desired
blends, containing various amounts of phospho-silk ﬁbroin
content and of two pH values, were prepared by casting and
mixing the appropriate quantities of unmodiﬁed ﬁbroin and
phospho-ﬁbroin solutions in a 24-well plate. 60 μL of MTX
stock solution was added, so that the drug ﬁnal concentration
of 0.2 mg mL−1 was established. Control samples were cast
without MTX. Cast solutions of 3 mL volume were left for
drying under constant air ﬂow in a laminar ﬂow hood for 2 to 3
days at room temperature. Dry ﬁlm thickness (at the bottom)
was measured using a caliper.
2.4. Quantitative Determination of Phosphate In-
corporated in Phospho-Silk Fibroin. Phosphate amounts
were determined according to the previously established
protocol.7
2.5. DLS and Electrophoretic Measurements of Silk
Fibroin and MTX. DLS was performed on a Zetasizer Nano
SZ instrument, run under Zetasizer Software v.7.02 (Malvern,
U.K.). Samples were equilibrated at 25 °C for 2 min prior to
measurements. For 0.5 g L−1 MTX, the material deﬁnition was
“polystyrene latex in water solvent” (all predeﬁned by
Malvern). For silk ﬁbroin the material was chosen as “protein”
(predeﬁned by Malvern), but the solvent was determined as
“silk ﬁbroin solution” (a user-created, custom pattern). Two
constants were introduced for this “solution”: refractive index,
RiSF, and solution viscosity, ηSF. RiSF was measured for 2 wt %
proteinaceous solution using an ATAGO RX-9000X refrac-
tometer (ATAGO Co., USA), resulting in a value of 1.335. ηSF
was theoretically estimated from the rearranged equation for
the intrinsic viscosity, [η]:26
η
η η
≡
C
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where ηS is the viscosity of solvent, i.e., water, with the value of
0.8872 cP and CSF is the ﬁbroin solution concentration. The
value of [η] was previously given26 as 0.23 CSF
−1, so that one
obtains ηSF = 1.4054 cP. For net charge estimations, involving
DLS, the results of forward scattering were exclusively used.
Electrophoretic mobility measurements were carried out on
the same equipment. Malvern disposable capillary cells of
DTS1070 type were used for both measurement kinds. All the
measurements were performed in triplicate.
2.6. Net Charge Estimations of Silk Fibroin and MTX.
Eﬀective valence, or net charge, values were calculated via a
stepwise process. Initially, a hydrodynamic radius, RH, of
material of interest was measured by DLS. Subsequently, D0,
was calculated from the rearranged Stokes−Einstein relation-
ship:
πη
=D k T
R60
B
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where kB is the Boltzmann constant, ηS is the solvent (and, for
the case of silk ﬁbroin, the solution) viscosity, T is the
temperature, and D0 is the diﬀusion coeﬃcient. Separately
measuring the electrophoretic mobility, μ, and substituting D0
and μ values into the equation of apparent valence z,
μ=z k T
D e
B
0 (3)
where e is the elementary charge, gives the ﬁnal result.24
Theoretical estimation of net charge for both compounds
was performed by the calculation of individual acid/base-
derived charges, corresponding to speciﬁc pKa, using the
Henderson−Hasselbalch equation.
2.7. Thermal Analysis of Silk Fibroin Derived
Materials. DSC measurements were performed with a
NETZSCH-DSC 200F3 instrument (Netzsch GmBH). The
experimental program consisted of sample pretreatment and
the measurement itself. Pretreatment included heating from
room temperature to 120 °C and holding the temperature for
10 min to induce sample dehydration. The temperature was
then lowered to 25 °C. From this point it was increased to 300
°C, and the measurement was performed. Constant energy ﬂow
rate of 10 °C min−1 was used in all steps. In the case of MTX
addition, its averaged weight was 0.431 ± 0.077 mg. Average
total sample weight was 2.28 ± 0.63 mg. During the analysis the
aluminum cell was swept with 50 mL min−1 N2 ﬂow.
2.8. In Vitro Release. The release kinetics of MTX in two
diﬀerent solutions (PBS, 0.1 M; ammonium bicarbonate,
NH4HCO3, 0.1 M) and two diﬀerent pH values (6.25 and
8.0) was studied. Both pH values are applicable to PBS and
NH4HCO3 solutions. The discrete pH values were chosen
according to the Sigma-Aldrich product datasheet (code
E0127), deﬁning that pH 8.0−8.5 is optimal for the protease.
Hence a lesser enzymatic activity was anticipated for the lower
pH. Silk ﬁbroin derived materials were incubated at 37 °C in
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the aforementioned solutions, of which only NH4HCO3
contained a protease, porcine pancreatic elastase (PPE, EC
3.4.21.36) at 1:100 elastase:substrate w/w ratio. At determined
time points, MTX release was quantiﬁed by absorbance
measurements at 403 nm against a standard absorbance
curve. To obtain kinetic values characterizing diﬀerent
conditions and materials, incubation during 4 h with 20 min
sampling was done. The buﬀers were ﬂashed each hour. The
release behavior of MTX from polymeric systems was
determined by ﬁtting the experimental data as described.7
Ritger−Peppas- and Higuchi-derived constants were designated
as KRP and KH, accordingly. The ﬁtting was performed in
OriginPro software, v8.5.0 (OriginLab Corporation, USA),
using “Linear ﬁt” routine.
2.9. Cell Culture. The human intestinal Caco-2 cell line
(ATCC HTB37) was maintained under a humidiﬁed
atmosphere containing 5% CO2 at 37 °C, in high glucose
Dulbecco’s modiﬁed Eagle medium (DMEM) with L-glutamine
and 1% nonessential amino acids, supplemented with 20% heat-
inactivated fetal bovine serum (FBS) and 1% antibiotic/
antimycotic solution (10 000 units mL−1 penicillin, 10 000 μg
mL−1 streptomycin, 25 μg mL−1 amphotericin).
2.10. Cell Proliferation Assay. MTS compound, in the
presence of phenazine ethosulfate, is bioreduced by cells into a
soluble formazan product with an absorbance maximum at 490
nm, thus assaying active cell metabolism.27 CellTiter 96
Aqueous One Solution, containing MTS, was used to assess
cell viability. Triplicates for each individual assay were
considered.
2.10.1. Test by Indirect Contact. (Phospho-) silk ﬁbroin
ﬁlms were disinfected by triple washings with antibiotic/
antimycotic solution and preconditioned with culture medium
devoid of FBS for 6 h at 37 °C. The medium was later
harvested and supplemented with 10% serum. This precondi-
tioned medium was then applied to previously seeded (1 × 105
cells mL−1) and adhered Caco-2 cells. The cells were further
incubated for 48 h, and the proliferation was assessed with
MTS. The assay was performed in duplicate.
2.11. Statistical Analysis. All assumptions were met prior
to data analysis. To investigate the kinetic modeling of MTX
release among diﬀerent pH cast silk ﬁbroin ﬁlms, the
dissolution constants of Higuchi (KH) and Ritger−Peppas
(KRP) mathematical models were considered. These kinetic
values were determined using diﬀerent strategies (KH, by ﬁtting
software; KRP, by ﬁtting and subsequent calculation), therefore,
distinguished statistical methods were applied for drug release
proﬁle comparisons. A factorial ANOVA [three factors: pH of
cast-ﬁlm (two levels: pH 7.2 and pH 3.5); type of ﬁlm matrix
(four levels: 0, 15, 30, 60% of serine residue modiﬁcation), and
type of incubation solution (four levels: PBS pH 8.0, PBS pH
6.25, PPE pH 8.0, and PPE pH 6.25)] was conducted to
evaluate the inﬂuence of pH on release rate of MTX-loaded SF-
ﬁlms, considering the Ritger−Peppas kinetic values. t test for
independent groups was applied to determine the inﬂuence of
pH on release rate of MTX-loaded SF-ﬁlms, considering the
Higuchi kinetic values. Wilcoxon matched pairs test was
considered to compare the kinetic proﬁle of MTX-loaded SF-
ﬁlms among mathematical models.
ANOVA analysis [two factors: pH of cast-ﬁlm (two levels:
pH 7.2 and pH 3.5) and type of ﬁlm matrix (four levels: 0, 15,
30, 60% of serine residue modiﬁcation)] was conducted to
investigate the inﬂuence of the MTX-loaded SF-ﬁlm
modiﬁcation degree (of serine residues) on cell proliferation.
Post hoc comparisons were conducted using Student−
Newman−Keuls (SNK). A P value of 0.05 was used for
signiﬁcance testing. Analyses were performed in STATISTICA
(v.7)
3. RESULTS
3.1. (Phospho-) Silk Fibroin Solutions: Production and
Net Charge Estimation. Phosphorylation of initial silk ﬁbroin
solution was made using the developed protocol and resulted in
≈60% of phosphorylation after 3−4 h. The phosphorylation %
is the percent of all sites, suitable for enzymatic phosphor-
ylation, that were successfully modiﬁed.7 Phosphorylation of
Ser residues in ﬁbroin was further analyzed by malachite green
for their % of released maximal phosphate (Table 1).
In an attempt to enhance MTX−ﬁbroin electrostatic
interactions and thus promote more prolonged drug release,
we initially theoretically estimated the charges of both
compounds as a function of pH, and speciﬁcally to ﬁbroin,
also as a function of its phosphorylation. The rationale for
doing this was the inability of existing tools to accurately
calculate net charge (z) of the phosphorylated protein. It can be
seen that phosphorylation level inversely correlates with overall
positive charge of a protein (Figure S1 in the Supporting
Information). The pH range between 3.5 and 4.0 was of
particular interest, since the extensively modiﬁed protein (60%
phosphorylated) and MTX possess opposite charges in that
interval. With pH increment, both proteinaceous solution and
the drug acquire negative charges, rendering electrostatic
interactions less favorable. This trend of silk charge change is
in agreement with the results obtained by in silico tools,
available online (for example, Protein Calculator v3.4, http://
protcalc.sourceforge.net), applied on full protein sequence
(accession number AF226688). To test the polymer−drug
interactions, two discrete casting pH values were chosen: 3.5
and 7.2. Phosphorylated ﬁbroin was produced, its pH value
adjusted, and net charge calculated, while MTX charge was
elucidated for two distinct pH values.
During the experimental estimation of net charges of both
compounds, they demonstrated a positive z values within acidic
pH range (Figures 1 and S2 in the Supporting Information).
This magnitude of charge is clearly seen for ﬁbroin solution
and, to a lesser extent, for MTX.
3.2. Optimization of Production of MTX-Loaded
Films. Considering the desired eﬀect of weaker electrostatic
repulsion between ﬁbroin and MTX, at acidic pH, we cast
Table 1. Evaluation of the Phosphorylated Content
(Phospho-Ser) by Malachite Green Reaction for Diﬀerent
Silk Fibroin Blendsa
blends elaborated for the characterization/analysis of
type
phosphorylation
degree, % DSC (batch 1)
MTX release
(batch 2)
cytotoxicity
(batch 3)
60 61.0 ± 1.11 59.95 ± 4.96 56.94 ± 2.52
30 29.9 ± 1.54 30.67 ± 2.4 32.61 ± 2.7
15 15.54 ± 2.76 16.32 ± 2.64 15.05 ± 1.92
aThe percentages denote phosphorylation extent of all possible sites.
The current quantiﬁcation was based on one assay (for each separate
batch type) with double sampling. The calculated data represent the
percentage from the maximally estimated value of inorganic phosphate
(Pi), released during phospho-Ser hydrolysis.
Molecular Pharmaceutics Article
dx.doi.org/10.1021/mp5004338 | Mol. Pharmaceutics 2015, 12, 75−8677
proteinaceous solutions at two discrete pH values and added
the drug. The ﬁrst casting was performed at nearly neutral pH
of 7.25 and the second at pH 3.5. During ﬁbroin solution
titration with HCl, a protein loss of ≈3% from its soluble
amount was detected. This happened due to the hydrophobic
self-aggregation of silk, where the local pH drop (in the
immediate environment of HCl) was the most signiﬁcant.28 To
avoid the possible gelation of acidiﬁed silk solution during the
drying process, considerable air ﬂow is needed. In the current
work, thicker ﬁlms obtained by solvent casting in tissue culture
test plates (3 mL of solution in a 3.29 mL well, of 7.45 cm2
bottom square) rendered methanol treatment (insolubility
induction of dried materials) dispensable. “Thicker ﬁlms” in
this context have increased thickness, related to the previously
employed approach,7 where 5 mL of solution was cast in a 10
mL Petri dish of 32.17 cm2 bottom square. The currently
obtained ﬁlms were of 0.08−0.12 mm or 0.12−0.16 ± 0.03 mm
thickness, originating from casting pH values of 3.5 and 7.2,
respectively.
3.3. Thermal Analysis of Silk Fibroin Derived Films.
The thermal analysis of silk ﬁbroin derived ﬁlms pursued two
goals: to demonstrate structural diﬀerences of dried materials
imposed by pH and phosphorylation, and to monitor existing
interaction between ﬁbroin and MTX. As seen in Figures 2 and
3, in comparison to neutral pH-cast ﬁlms, acidic pH derived
materials exhibit increased amount of β-sheet structures,
resulting in the smoothening of thermogram curves.29 Silk
ﬁbroin glass transition temperature (Tg) characterizes a
structural shift, preceding the formation of β-sheet arrange-
ments. For the material cast at neutral pH with the following
phosphorylation degree of 0%, 15%, and 30%, Tg onset was
≈135−145 °C; a similar result was observed solely for the
unmodiﬁed material (0%), cast at acidic pH (Figures 2A and S3
in the Supporting Information). Thermodynamically, acidic pH
favors silk self-aggregation,28 therefore Tg is not observed for
pH 3.5-cast ﬁlms. A crystallization peak is only clearly evident
for 0% phosphorylation for the pH 7.2-cast ﬁlm (≈217 °C;
Figure 2A). Fainter crystallization events could still be observed
Figure 1. Experimental estimation of silk ﬁbroin and methotrexate (MTX) charges as a function of pH. (A) Full-scale representation. (B) Zoomed-
in representation. The increase of negative charge resulting from phosphorylation is observed. For better clarity, additional curves, corresponding to
material types 15% and 30% (appearing between 0% and 60% types), are provided as Supporting Information.
Figure 2. Thermal analysis of silk ﬁbroin ﬁlms, without (“MTX−”) methotrexate embedded. (A) Fibroin ﬁlms cast at pH 7.2. In panel ( A), the
marked Tg applies to the material of 0% modiﬁcation only. (B) Fibroin ﬁlms cast at pH 3.5. Crystallization peaks are denoted by asterisks. Where
possible, the onset temperature glass transition (Tg) is indicated.
Molecular Pharmaceutics Article
dx.doi.org/10.1021/mp5004338 | Mol. Pharmaceutics 2015, 12, 75−8678
for 0 and 15% phosphorylated matrices, cast at acidic and
neutral pH, respectively (Figures 2B and S3C in the Supporting
Information). For all the materials at diﬀerent phosphorylation
degrees the decomposition occurs at 275 °C. Some ﬁlms
presented a bimodal decomposition endotherm,30 as can be
seen on Figures 2B and 3B. This fact may be due to the
nonuniformity of the material that causes stepwise energy
absorption.
The DSC curve of MTX powder presents several distinct
peaks (Figure 4). The ﬁrst peak, at ≈175 °C, can be attributed
to pseudomelting or dissolution,31 while the second peak, at
≈224 °C, is mainly due to solid−solid transition32 or partial
melting of the drug crystalline form.31 Finally, MTX has a short
recrystallization peak at ≈238−247 °C, which precedes its
thermal decomposition at 252 °C. In general, the MTX
thermogram displays gradual, ongoing crystallization, through-
out the entire observation. Thus, the positive enthalpy, or
absorbed heat, is constantly decreasing.
The addition of the drug to the cast silk solution suggests
variable interactions between MTX and ﬁbroin upon ﬁlm
drying. When comparing the DSC curves for silk-based ﬁlms
with and without the MTX, independently of the phosphor-
ylation degree of the material, a similar trend of emerging
MTX-derived thermal peaks was observed. The three main
events, developed as only MTX powder had been heated, are
depicted in Figure 4. Consequently, addition of the drug to the
nonphosphorylated material induced the formation of a
pseudomelting peak at 150 °C with a partial decomposition
at 240−250 °C (designated by ﬁlled (▶) and empty (▷)
arrows, respectively, in Figures 3 and S4 in the Supporting
Information). MTX incorporation also shifted the main
decomposition endotherm. This shift was signiﬁcant for the
0% phosphorylation material cast at pH 7.2 (280→ ≈249 °C),
but less pronounced for the other materials (Figures S3D and
S4D in the Supporting Information). Moreover, a clear
decrease in the energy absorption (Eabs) was evident for all,
except 60% modiﬁed and near neutral pH-cast matrixes
(compare Figures 2, 3, and S3 and S4 in the Supporting
Information). Acidic pH cast materials of 0% and 15%
phosphorylation demonstrated slight and more pronounced
increase of Eabs upon MTX addition, respectively. 30% and 60%
material types had mainly and highly decreased Eabs,
respectively, with MTX incorporated. However, it cannot be
concluded that the stronger drug−polymer interaction is
evident for 7.2 pH derived materials, based solely on the
presented DSC ﬁndings.
3.4. In Vitro Release Proﬁling of Incorporated MTX.
The structure of the material inﬂuences the incorporated MTX
release proﬁle. Prepared phospho-ﬁbroin ﬁlms were incubated
in PBS with or without protease (porcine pancreatic elastase,
termed as PPE solution). It is important to mention that no
methanol treatment was performed prior to incubation. From
our previous work, it is known that the pretreatment of the
material with methanol can lead to a signiﬁcant loss of
incorporated drug (up to 55% of its initial content7). Thus, it is
important to carefully choose protocols that preserve the drug
prior to its actual release.
Since preliminary tests with MTX indicated rapid drug
dissolution (data not shown), a short-term proﬁling with
frequent sampling was conducted. The release proﬁles, depicted
Figure 3. Thermal analysis of silk ﬁbroin ﬁlms, with (“MTX+”) methotrexate embedded. (A) Fibroin ﬁlms cast at pH 7.2. (B) Fibroin ﬁlms cast at
pH 3.5. Several, though not all, methotrexate-related peaks are denoted with arrows. Each arrow type (▶, pseudomelting, or ▷, recrystallization
coupled to partial decomposition) corresponds to a distinct thermal event, resulting from the incorporated MTX.
Figure 4. Representation of the DSC curve of methotrexate (MTX)
powder. The three main thermal events are indicated: ﬁrst (▶),
pseudomelting; second (without special designation), solid−solid
transition; third (▷), recrystallization coupled to partial decom-
position. Due to the speciﬁcity of the used procedure (section 2.7), the
MTX dehydration endotherm is not shown in the current
presentation.
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in Figure 5, reveal several important conclusions about the drug
dissipation from the ﬁlms. For all incubation conditions, the
release of 80% of MTX was achieved within 2 h and there is no
signiﬁcant diﬀerence between PBS- or PPE-mediated release for
neutral pH-cast ﬁlms. A diﬀerent proﬁle was seen for the acidic
pH derived materials, where protease facilitated drug
dissolution (Figure 4B). In the latter case, it is possible to
denote the burst phase during the ﬁrst hour of incubation,
resulting in nearly complete drug release (>90%). It is worth
mentioning that each individual curve in Figure 4 results from
the average of four independent proﬁling experiments,
corresponding to 0%, 15%, 30%, and 60% of phosphorylation
content. Such representation was chosen because of the
existence of considerable similarity between discrete release
proﬁles for each matrix type (Figure S6 in the Supporting
Information). Thus, for simplicity of the display, only averaged
proﬁling curves for two major matrix types (neutral versus
acidic pH cast) were presented, which nevertheless does not
mean that the later reported kinetic values resulted from the
calculation, involving cross-averaging of materials with varying
phosphorylation.
Two theoretical approaches were implemented in order to
better understand the release proﬁling of MTX from the
phosphorylated materials, namely, Ritger−Peppas semiempir-
ical and Higuchi models.33−35 For Ritger−Peppas, the constant
KRP and diﬀusion (or release exponent) n values were
estimated, similarly to the KH diﬀusion value for Higuchi
method.
The release mechanism and characteristics of both macro-
molecular network system and the drug can be deduced from n
and KRP values by applying the Ritger−Peppas (RP) model to
release proﬁles. Software-given n values suggest super Case-II
transport36 for all the ﬁlms incubated at pH 8.0 (Figure 6A).
Near-neutral pH-cast matrixes, incubated in PBS at pH 6.2, also
demonstrate super Case-II transport values. Nevertheless these
are very similar in between and close to the values
characterizing a Case-II mechanism (for which n = 1;37 average
of the presented four amounts is 1.184 ± 0.036; Figure 6B).
Other materials, cast at pH 7.2 and pH 3.5 and immersed in
PPE and PBS, respectively, have an anomalous release
mechanism (for which the inequality 0.5 < n < 1.0 holds).
Finally, pH 3.5-cast and pH 6.2 PPE immersed ﬁlms again
demonstrate a super Case-II release process. Importantly, n
values were not available for all the conditions examined. For all
the materials in both casting groups, pH 8.0 PPE-assisted MTX
release resulted in an initial burst phase that was so great that it
rendered it impossible to apply RP modeling. Accordingly,
MTX release from 15% and 30% modiﬁed matrixes, acidic pH
cast, in pH 6.2 PPE-assisted incubation generated drug burst,
noncompliable with RP conditions.37 Anomalous transport
points to a complex release process, resulting from coupling of
solvent diﬀusion into the material and its subsequent
relaxation.38 Case-II and super Case-II mechanisms relate to
the state of rapid solvent mobility due to increased polymer
relaxation,37,39 provoking massive release of entrapped
compound. The only diﬀerence between the latter two
situations is that, in a super Case-II system type, saturation of
the release curve is reached faster.
MTX diﬀusion values from the RP model, KRP, are presented
in Figure 6C,D. In the RP model, pH 8.0, PBS-immersed
matrixes of both casting groups seem to release the drug more
easily upon lesser phosphorylation, although for neutral pH-
cast this tendency is more prominent (Figure 6C). For
incubation at pH 6.2, both PBS- and PPE-immersed matrixes
of the 7.2-casting group showed the aforementioned trend
(Figure 6D). Surprisingly, the PPE-mediated diﬀusion sub-
group manifested decreased KRP values. The 3.5-casting group
in PBS incubation did not display a considerable bias, and PPE-
incubated values were high (Figure 6D). It can be seen that KRP
values for incubation pH 6.2 substantially repeat the tendency
of n values (compare panels B and D of Figure 6).
The Higuchi model derived diﬀusion parameter, KH, is
depicted in Figure 7. Being a more simpliﬁed model, the
Higuchi model made it possible to ﬁt the empirical data for all
of the conditions. Thus, KH was obtained directly from the
ﬁtting algorithm. From the incubation buﬀers of two discrete
pH values it can be concluded that, akin to KRP, KH values
undergo gradual increase as modiﬁcation levels drop (Figure 7).
But the KH increment within each group is more prominent
than that of KRP. The clear exception is constituted by a pH 3.5-
cast group of materials, incubated with PBS, showing somewhat
decreased diﬀusion of MTX within a group, as a function of
phosphorylation. It can be also stated that pH 8.0 facilitates
drug release.
Figure 5. Release proﬁling of silk ﬁbroin ﬁlms with incorporated MTX. (A) Fibroin ﬁlms cast at pH 7.2. (B) Fibroin ﬁlms cast at pH 3.5. Each curve
is an averaged value of the four discrete proﬁles, corresponding to 0...60% phosphorylated material. Examples of individual release proﬁles are
presented in Figure S6 in the Supporting Information.
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Based on statistical analysis, performed for KRP and KH, it is
evident that for KRP no signiﬁcant diﬀerences were observed
among values of two major types of MTX-loaded ﬁlms (7.2-
versus 3.5-cast). The phosphorylation level does not inﬂuence
KRP, yet the incubation solutions do. Speciﬁcally, pH 7.2-cast
matrixes of 60% modiﬁcation, immersed in pH 6.2 PPE,
correspond to the lowest KRP, and this value is diﬀerent from all
other conditions, conversely to pH 3.5-cast, nonmodiﬁed
matrixes, incubated in pH 6.2 PPE, where 0% and 60%
correspond to the highest KRP. KH value analysis reveals that no
diﬀerences were observed among values of two major types of
MTX-loaded ﬁlms, considering percentage of degree mod-
iﬁcation (0...60% phosphorylation), however, various incuba-
tion solutions were signiﬁcantly diﬀerent. Independently of pH
value (3.5 or 7.2) of the cast ﬁlms, no diﬀerences among
modiﬁcation degree were encountered, while all incubation
solutions observed were diﬀerent among themselves.
3.5. Indirect Contact Eﬀect on Cell Proliferation.
According to the literature40,41 and our previous experience,7
elevated hydrophilicity disfavors cell attachment. Therefore, it
was decided to evaluate the bioactivity of the ﬁlms on
mammalian cells by indirect contact. MTX-loaded ﬁlms were
incubated with cell culture medium as described, allowing the
MTX to release into the medium. Cells were then cultivated in
contact with the preconditioned medium, and their prolifer-
ation was monitored. Based on Figure 8 it is evident that
neutral-cast materials possess higher MTX retention than their
acidic pH cast counterparts. As expected, MTX acted as a
nonproliferative agent. The proliferation rate was lower when
the MTX release was higher. Additionally, ﬁlms with higher
extent of phosphorylation were able to retain the drug for
longer time. This conclusion is clear from both casting pH
values, however, in the neutral-derived ﬁlms the trend falls
within statistical error, while in the acidic pH derived it does
not.
Figure 6. Kinetic values, obtained from substitution of MTX release proﬁling data to the Ritger−Peppas (RP) model. The incubation of ﬁlms in two
distinct media (PBS or PPE) was done. Two discrete pH values of 8.0 or 6.2 were used. (A, B) Release exponent n values for diﬀerent
phosphorylated silk ﬁbroin ﬁlms, computed by model. Direct output of a ﬁtting software. (C, D) For diﬀerent matrixes, RP model-derived diﬀusion
signiﬁcative, KRP, was calculated substituting n values to the empirical equation, described previously.
34 Data are reported with standard error and
based on one release experiment with double sampling.
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4. DISCUSSION
The current research examined the aspects of MTX−silk ﬁbroin
interactions in a changing environment of solution pH and silk
phosphorylation levels. Owing to the hydrophobic nature of
silk ﬁbroin, it was our working hypothesis to examine whether a
prolonged, time-controlled release of an incorporated, relatively
nonhydrophilic drug,42 MTX, could be accomplished. The
common practices are encapsulations of compounds into
environments of similar hydrophobicity or hydrophilicity. A
considerable amount of examples can be found in the literature
(ref 43 and references within), supporting this notion. From
this perspective, the compartment of the ﬁbroin matrix was
assumed to be suitable for MTX incorporation. The basis for
sustained drug release was theoretically regarded to its low
solubility in aqueous solutions. Hence, by tailoring silk
hydrophobicity through its chemical alterations a trial was
made to create the conditions of favored MTX retention within
a ﬁbroin matrix.
The mechanism of ﬁbroin self-association (whether during
natural spinning process or in the cast regenerated ﬁbroin
solutions) was postulated to be a thermodynamically favored β-
sheet hydrophobic aggregation.44,45 It was also established that
silk ﬁbroin phosphorylation impedes ﬁne β-sheet stacking in
the secondary protein conformation.7,46 In this work, diﬀerent
blends (or batches) of matrixes were used for all the studies
because the physical amount of the elaborated material makes it
very hard to use in all three tests. Moreover, we would like to
demonstrate the repeatability and consistency of the production
method. As can be seen, very similar materials are obtained (in
terms of phosphorylation, Table 1) for diﬀerent batches. To
examine the nature of occurring interactions, two distinct pH
values were tested (3.5 versus 7.2). At low pH, actual net
charges of both protein and drug appear to be considerably
higher than their theoretical values. The measured z values
Figure 7. Kinetic values, obtained from substitution of MTX release proﬁling data to the Higuchi model. The incubation of ﬁlms in two distinct
media (PBS or PPE) was done. Two discrete pH values, 8.0 and 6.2, were used. Higuchi diﬀusion, KH, values for diﬀerent phosphorylated silk ﬁbroin
ﬁlms were computed by the corresponding model. Direct output of a ﬁtting software. Data are reported with standard error and based on one release
experiment with double sampling.
Figure 8. Viability of Caco-2 cell line, cultivated on lixiviates, derived from 6 h incubation of growth medium with silk ﬁbroin MTX-loaded ﬁlms. (A)
pH 7.2-cast ﬁlms. (B) pH 3.5-cast ﬁlms. “+” and “−” denote the MTX-loaded or -devoid ﬁbroin materials. DMEM = cell growth medium only, a
positive control. MTX = methotrexate at 0.2 mg/mL concentration, a negative control. Statistically signiﬁcant diﬀerence is denoted by an asterisk.
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were higher than could be expected, based on the theoretical
estimation (Figures S1 and S2 in the Supporting Information).
This may be attributed to increased RH estimation by DLS,
resulting in decreased D0 (see section 2.6), since the possible
augmentation of μ is inconsistent with the tendency, previously
reported for this variable.47 In particular, ﬁbroin is known to
rapidly form aggregates below pH 4.59.28 These less soluble
structures decrease diﬀusion rate23 and result in higher
estimation of a hydrodynamic radius, which leads to the
calculation of elevated net charge. The hydrophobic clustering
per se could however cause enhanced charge accumulation,48 in
this case, positive. Given the fact that at nearly neutral pH
electrostatic repulsion between both components should also
exist, it is necessary to clarify why MTX aﬃnity to ﬁbrous ﬁlm
was signiﬁcantly lower at acidic pH. It is possible that, while
forming a dense, β-sheet clustering, MTX is mainly excluded
from the resulting structure, since no favorable electrostatic
interaction is present, or it is not strong enough.
DSC analysis further enforces the observation of varying
polymer−drug interactions as a function of pH. For silk ﬁbroin,
its self-assembly28 during the drying process is comparable to
that induced by methanol treatment of dried ﬁbrous materials,
obtained by solvent casting.7,29,49,50 The incorporation of
phosphate groups causes Tg to shift slightly to lower values,
inducing a plasticization eﬀect51 (Figures 2 and S3 in the
Supporting Information). Extensive phosphorylation (60%)
eliminates Tg completely (Figure 2); moreover, Tg cannot be
determined precisely (or possess a single value) in semicrystal-
line polymers like silk ﬁbroin and similar ones.52,53 Broad glass
transition curves are ascribed to the composition heterogeneity
of the elaborated materials, composed of polymer blends. For
that reason only the onset of glass transition is marked in the
DSC curves. Additionally, the phosphorylation per se reduces β-
structure formation,46 thus decreasing crystallinity and masking
possible Tg by broadening distribution of relaxation times in the
polymer.
Maximal MTX dehydration occurred at 91 °C, however this
step was a part of a pretreatment phase of DSC experiment (see
section 2.7) and, therefore, is not seen during the recorded
measurement. The thermal results and the characteristic peaks
indicate that the drug used was of its trihydrate form.32 MTX-
derived pseudomelting peak and the decomposition peaks shift
to lower temperatures for pH 7.2-cast ﬁlms. The shift of both
pseudomelting (▶) and recrystallization coupled to decom-
position (▷) endotherms of MTX toward lower temperatures
(175 → 150 °C and 252 → 240−250 °C; Figures 3 and S5 in
the Supporting Information) suggests strong drug−polymer
interaction.31 Of special magnitude is the MTX pseudomelting
endotherm observed in nonmodiﬁed, neutral-cast ﬁbroin
(Figure S5A in the Supporting Information), traversing other
curves. The cause of such behavior is unknown and cannot be
explained on solely hydrophobicity basis, since the same ﬁlm
type, corresponding to acidic casting and thus considered more
hydrophobic (Figure S5B in the Supporting Information),
shows no such profound peak. Much less evident is the thermal
event, encountered for 15%-phosphorylated silk. More
extensively modiﬁed matrixes of pH 7.2 show no MTX-derived
events. The drug pseudomelting peak, although weakly
pronounced for pH 3.5-cast ﬁlms (0% and 15%), is also
shifted. This is the only peak type, clearly distinguishable for
the acidic pH cast materials (Figure S5 in the Supporting
Information). MTX decomposition-derived peaks are present
for both discrete pH values at 0%-modiﬁed ﬁbroin only. The
described diﬀerences in DSC results, involved with various
materials, could be attributed to the diﬀerent aggregate state of
both constituting proteins and MTX in the samples.31
Additional phenomena,54 such as ﬁlm thickness, intermolecular
mobility of chains within the polymer, or its previous thermal
history, probably explain the example of out-of-trend DSC
curve for 30% modiﬁed ﬁbroin, acidic-cast (Figures S4B and
S5B in the Supporting Information).
In vitro release proﬁling of MTX made it possible to aﬃrm
that the release process is somewhat more facilitated from the
matrixes elaborated at acidic pH. The release exponent n values
were not always consistent with those expected for a speciﬁc
material type, for example, anomalous-type release for pH 7.2-
and 3.5-cast and pH 6.2 PPE- or PBS-incubated, respectively;
Figure 6B. In that situation one would expect to obtain higher
n, corresponding to (super) Case-II mechanism, especially in
PPE-assisted process. Yet, the actual inability to apply RP
modeling on the PPE-mediated proﬁles for pH 8.0 incubated
matrixes, both neutral- and acidic-cast, underlines a strong burst
release phase that surpasses 60% of total drug amount, initially
found in the ﬁbroin. Thus, at optimum pH, PPE promotes the
drug release from both major groups of materials. Moreover,
for pH 3.5-cast ﬁlms even at pH incubation of 6.2, in PPE-
mediated process, n values surpass those of pH 7.2-cast ﬁlms.
Again, not all the n values were calculated, due to RP model
restriction (but only those corresponding to 60% and 0%
modiﬁcations, last two columns on the right in Figure 6B),
which signiﬁes a sizable burst eﬀect upon initial MTX release.
The burst is also seen at PBS incubation of pH 8.0 for 3.5-cast
ﬁlms (Figure 6A). This phenomenon of elevated burst in
acidiﬁed ﬁbroin-derived materials needs explanation. Similarly
to the reported ﬁndings,55,56 increased migration of MTX
during the drying of cast ﬁlms may result in a nonhomogeneous
distribution of drug in the formed matrix and provoke a burst
release. Another plausible cause for lesser MTX retention inside
the acidiﬁed-cast silk matrixes is their increased (in comparison
with neutral pH-cast matrixes) heterogeneity. Heterogeneity
may result from formation of cracks or perforations during the
device fabrication. Indeed, pH 3.5-cast materials were more
brittle than their pH 7.2-cast counterparts. Examples are known
of phenomena when formulations have been made by solvent
evaporation and an increased removal of the solvent causes
elevated porosity.57,58 All of the above considerations make the
statement regarding super Case-II release (bearing release
exponent n >1) of MTX from the currently fabricated materials
quite expected. Besides, super Case-II-controlled release was
already observed for caﬀeine-loaded karaya gum hydrophilic
matrixes,36 alprenolol-incorporated cellulose-derived tablets;59
cross-linked chitosan membranes in aqueous media swelled in a
super Case-II manner.60
As for diﬀusion-related constants, both models show
signiﬁcant diﬀerence of the derived values for neutral
solution-cast ﬁlms, but not for acidic one. The two kinetic
models used can be compared through their KRP and KH values,
as neither KRP nor KH has obvious deﬁnition (although
describing similar concepts). KRP alternatively can be seen as an
interaction parameter between a drug and the material
harboring it.33 Within each model, RP did not demonstrate
diﬀerences among KRP values of the ﬁlms, yet statistical
diﬀerences among KH values of ﬁlms, obtained by the Higuchi
model, seem to be more discriminative. This may stem from
the nature of calculations involved in both approaches. KH
parameter is given by ﬁtting software directly, while KRP is
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derived from n. Moreover, RP approach implies that only the
proﬁle data, obtained from 60% release of the initial content,
may be included in calculations,33−35 which does not hold for
the Higuchi model, where the full range of release values can be
used.
Wilcoxon’s matched pairs test showed that, for neutral-cast
materials, KRP- and KH-derived values are signiﬁcantly diﬀerent.
Based on t-test, the Ritger−Peppas model reports no
diﬀerences in KRP values among ﬁlms, yet Higuchi shows
statistical diﬀerences among KH values of ﬁlms.
Finally, the indirect contact assay results support the
observations that acidiﬁed solution-cast materials release the
drug intensively, whereas neutral solution-derived do not.
Importantly, a negative correlation between phosphorylated
content and MTX release is evident for the acidiﬁed
formulations. This underlines the importance of phosphor-
ylation in disrupting β-sheet structures, as reported previ-
ously,7,46 by creating a more favorable environment for MTX
retention.
In summary, it can be concluded that our initial assumption
for the enhanced MTX retention within a dense, acidiﬁed
hydrophobic matrix of silk ﬁbroin was not proved. We were not
able to establish time-controlled release of the drug, although
the term “time-controlled” itself is not precisely deﬁned, and
there exists a distinction between burst release and short-term
controlled release, observed for several systems.61 In our case
the statement that a prolonged time-controlled release was not
established will be more correct. According to the Biopharma-
ceutics Classiﬁcation System (BCS), MTX falls in more than
one category of compounds’ solubility:42 it can be highly or less
soluble, depending on the experimental conditions. Indeed,
MTX solubility mainly depends on the ionization of its α- and
γ-carboxylic groups62 (pK1 ≈ 3.22 and pK2 ≈ 4.53,
respectively)63 and slightly on the state of a basic pteridine
moiety (pK3 ≈ 5.62).
63 Hence, during casting solution
preparation, the partial aggregation of the added solubilized
MTX to acidiﬁed silk ﬁbroin solution occurred, corroborating
previous observations of MTX precipitation as a function of
pH.62 Likely drug migration to the superﬁcial layers of forming
materials during their drying caused nonuniformity of its
distribution. Thus, despite the increase of protein self-
aggregation at acidic pH, it does not enhance the drug
retention inside the ﬁlm matrix. Actually, a lesser polymer−
drug association was obtained, though not because of decreased
aﬃnity of MTX to the ﬁbroin, but resulting from heterogeneity
of its ﬁnal distribution in the ﬁlms. Kinetic parameters, obtained
throughout the current study, points to basic pH and PPE
enzyme as factors, facilitating the drug release. It is no surprise
that increased ionization or matrix degradation promotes MTX
solubilization or the release from the ﬁlms. However, with
respect to PPE, the option to drive the MTX release under
proteolysis is of questionable value, so far as signiﬁcant burst
eﬀect occurred. If the designed material would possess a
prolonged time-controlled release per se, PPE contribution to
the process would probably be considered as beneﬁcial. Future
perspectives on enhancing phosphorylated silk-based ﬁlms may
include physical manipulations on the cast material, using lesser
molecular weight ﬁbroin as a source for downstream
processing, or adding plasticizers like glycerol. The treatments
mentioned above were found to increase dried ﬁlms’
plasticity,64 ﬂexibility and water retention,65 or alter release
rate of the incorporated compound from a ﬁlm and the rate of
ﬁlm degradation.66 Later, if the drug is to be added, it may
experience diﬀerent (desirably prolonged) release kinetics.
On the contrary, nearly neutral solution-casting produced
materials with slower drug release. The explanation for
decreased density of those fabricated ﬁlms and the following
more uniform MTX incorporation, resulting in its slower
dissipation, is quite reasonable. Several works reported a
connection between elevated content of β-sheet crystals and
the formation of high packing density in silk ﬁbroin.67−70
Crystallinity is directly related to β-sheet hydrophobic stacking,
and in the silk solution it is favored at dehydration,68 shear
stress,71 heating,28 and pH drop,28 among other modes. The
conclusion for decreased density of pH 7.2-cast ﬁlms stems
from previous observations of decreased β-sheet amounts in
phosphorylated ﬁbroin by circular dicroism46 and deconvolved
FTIR spectra, reﬂecting on secondary structure analysis.7
Moreover, being that none of the above treatments for
crystallinity induction was done on neutral pH-cast ﬁlms,
they are considered to possess a less tight structure. Since the
electrostatic interactions are considered to be mainly repulsive
in both cases (Figures 1 and S1 and S2 in the Supporting
Information), the matrix structure has a determinative eﬀect on
the drug retention.
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